Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
The Best Computer games Ever - 2See the 'amazing' photos of Earth taken on historic Artemis II moon mission
- 3Air superiority and long-range strikes: what China's war games say about how it might assault Taiwan
- 4Instructions to Help a Friend or family member Determined to have Cellular breakdown in the lungs
- 5December's overlooked meteor shower peaks next week — will the Ursids surprise us?
- In these U.S. groups, deaths now exceed births. What’s happening?
- The Solution to Defeating Tarrying: Systems for Expanded Efficiency
- Electric Vehicles for Eco-Accommodating Driving
- Dutch police probe a small blast outside a pro-Israel Christian center
- Party Urban areas of the World
- Astrophotographer captures rare footage of the Hubble Telescope crossing the sun (video)
- Red Crescent: More than 100,000 civilian structures damaged in Iran
- Islamabad: Iran allows 20 Pakistani ships through Strait of Hormuz
- Uranus's small moons are dark, red, and water-poor
